ID: ALA4462741

Max Phase: Preclinical

Molecular Formula: C17H13F3N2O6

Molecular Weight: 398.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)CNC(=O)c1c(O)c2c(n(Cc3cc(F)c(F)cc3F)c1=O)COC2

Standard InChI:  InChI=1S/C17H13F3N2O6/c18-9-2-11(20)10(19)1-7(9)4-22-12-6-28-5-8(12)15(25)14(17(22)27)16(26)21-3-13(23)24/h1-2,25H,3-6H2,(H,21,26)(H,23,24)

Standard InChI Key:  LGUYPCRXJIHSNZ-UHFFFAOYSA-N

Associated Targets(Human)

Egl nine homolog 3 250 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Egl nine homolog 1 1702 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hypoxia-inducible factor prolyl hydroxylase 1 404 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.29Molecular Weight (Monoisotopic): 398.0726AlogP: 0.86#Rotatable Bonds: 5
Polar Surface Area: 117.86Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.20CX Basic pKa: CX LogP: -0.24CX LogD: -3.70
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.84

References

1. Liu P, Wang L, DuBois BG, Colandrea VJ, Liu R, Cai J, Du X, Quan W, Morris W, Bai J, Bishwokarma B, Cheng M, Piesvaux J, Ray K, Alpert C, Chiu CS, Zielstorff M, Metzger JM, Yang L, Leung D, Alleyne C, Vincent SH, Pucci V, Li X, Crespo A, Stickens D, Hale JJ, Ujjainwalla F, Sinz CJ..  (2018)  Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia.,  (12): [PMID:30613325] [10.1021/acsmedchemlett.8b00274]

Source